
Two London hospitals will launch trials next year to determine whether the active ingredients in medicinal cannabis could help treat people with treatment-resistant epilepsy.
Researchers from University College London and Great Ormond Street Hospital will investigate whether cannabidiol (CBD) and tetrahydrocannabinol (THC) could have a therapeutic effect for those with the condition.